IF by specialty › Oncology
JAMA Oncology — Impact Factor
The 2025 Impact Factor of JAMA Oncology is 23.9 (Q1 in Oncology; subscription or hybrid).
- Impact Factor
- 23.9 JCR 2025
- JCR category
- Oncology
- Quartile
- Q1 in Oncology
- Publisher
- AMA
- Open access
- subscription or hybrid
- IF source
- manusights.com
Position within the field
Ranked 11 of the 42 journals in Oncology on this site (top 50%).
Oncology journals with a similar Impact Factor
- Lancet Oncology IF 33.7
- Cancer Discovery IF 29.5
- Nature Cancer IF 28.0
- Journal of Thoracic Oncology IF 23.3
- Cancer Research IF 22.6
- Journal for ImmunoTherapy of Cancer IF 11.7
About this value
The Journal Impact Factor of JAMA Oncology (JCR 2025, released June 2026) is 23.9. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Oncology.